Rhabdomyosarcoma classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Rhabdomyosarcoma}}
{{Rhabdomyosarcoma}}
{{CMG}};{{AE}} {{PSK}}
{{CMG}};{{AE}} {{S.M}}
==Overview==
==Overview==
Rhabdomyosarcoma may be classified according to the "International classification of rhabdomyosarcoma" into five subtypes: Alveolar rhabdomyosarcoma, embryonal rhabdomyosarcoma, botryoid rhabdomyosarcoma, spindle cell rhabdomyosarcoma, and anaplastic rhabdomyosarcoma.


==Classification==
==Classification==
Line 14: Line 13:
**Alveolar RMS
**Alveolar RMS


This system attempts to combine elements of the previous systems and correlate these with prognosis based on tumor type. Rhabdomyosarcomas are classified into five subtypes:
 
*Alveolar rhabdomyosarcoma
*Alveolar rhabdomyosarcoma
**Usually affects young adults
**Usually affects young adults

Revision as of 16:19, 11 January 2019

Rhabdomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyosarcoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyosarcoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyosarcoma classification

CDC on Rhabdomyosarcoma classification

Rhabdomyosarcoma classification in the news

Blogs on Rhabdomyosarcoma classification

Directions to Hospitals Treating Rhabdomyosarcoma

Risk calculators and risk factors for Rhabdomyosarcoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Classification

Histologic classification of rhabdomyosarcoma

  • The international classification of rhabdomyosarcoma (RMS) was created by the Intergroup Rhabdomyosarcoma Study group (IRSG) therapeutic trials (IRS-I to IV).[1][2]
  • The four main subgroups are:
    • Embryonal RMS
    • Botryoid and spindle cell (leiomyomatous) RMS
    • Sclerosing and spindle cell RMS with MyoD1 mutation
    • Alveolar RMS


  • Alveolar rhabdomyosarcoma
    • Usually affects young adults
    • Early metastasis is common
  • Embryonal rhabdomyosarcoma
    • Usually affects children <10 years of age
    • Typically locally invasive
  • Botryoid rhabdomyosarcoma
  • Spindle cell rhabdomyosarcoma
  • Anaplastic rhabdomyosarcoma

Several additional subtypes of rhabdomyosarcoma exist that do not fit into the International Classification scheme:

  • Pleomorphic rhabdomyosarcoma: Usually occurs in adults rather than children.
  • Sclerosing rhabdomyosarcoma: It is a rare rhabdomyosarcoma subtype.

References

  1. Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, Parham DM; et al. (1998). "Intergroup Rhabdomyosarcoma Study: update for pathologists". Pediatr Dev Pathol. 1 (6): 550–61. PMID 9724344.
  2. Hicks J, Flaitz C (2002). "Rhabdomyosarcoma of the head and neck in children". Oral Oncol. 38 (5): 450–9. PMID 12110339.

Template:WH Template:WS